Dong Seop Kim, Ki-Suk Kim, Ki Hwan Choi, Hankwang Na, Joo-Il Kim, Won-Ho Shin, Eun-Joo Kim
Index: Drug Chem. Toxicol. 29(3) , 303-12, (2006)
Full Text: HTML
Some fluoroquinolones have been reported to induce QT interval prolongation associated with the onset of torsades de pointes (TdP), resulting in a life-threatening ventricular arrhythmia. We investigated the cardiac electrophysiological effects of two new fluoroquinolones, gemifloxacin and balofloxacin, by using conventional microelectrode recording techniques in isolated rabbit Purkinje fiber and whole-cell patch-clamp techniques in human ether-á-go-go related gene (hERG)-transient transfected CHO cells. Gemifloxacin had no significant effects on the resting membrane potential, total amplitude, action potential, and Vmax of phase 0 depolarization at concentrations up to 30 microM, but gemifloxacin at 100 microM significantly decreased total amplitude (p < 0.01). These values of gemifloxacin (30 and 100 microM) were approximately 25- and 83-fold more than the free plasma concentration of 1.2 microM in a single therapeutic injection in humans. For I(hERG), the IC(50) value was about 300 microM. Balofloxacin had also no significant effects on the resting membrane potential, total amplitude, action potential duration, and Vmax of phase 0 depolarization at concentrations up to 30 microM, but balofloxacin at 100 microM significantly (p < 0.01) prolonged action potentials at both 50% repolarization (APD(50)) and 90% repolarization (APD(90)). These values of balofloxacin (30 and 100 microM) were approximately 6.8- and 23-fold more than the free plasma concentration of 4.4 microM in a single therapeutic injection in humans. For I(hERG), the IC(50) value was 214 +/- 14 microM. Therefore, our data suggested that in the electrophysiological aspect, gemifloxacin and balofloxacin may have no torsadogenic potenties up to 30 microM.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Balofloxacin
CAS:127294-70-6 |
C20H24FN3O4 |
Determination of the new fluoroquinolone balofloxacin and it...
1995-06-01 [Arzneimittelforschung 45(6) , 716-8, (1995)] |
Photoallergenicity of a fluoroquinolone antibacterial agent ...
1998-01-01 [Skin Pharmacol. Appl. Skin Physiol. 11(4-5) , 232-40, (1998)] |
Gatifloxacin, moxifloxacin, and balofloxacin resistance due ...
2009-01-01 [Ophthalmic Res. 42(1) , 43-8, (2009)] |
Alterations of protein complexes and pathways in genetic inf...
2012-09-01 [Mol. Biosyst. 8(9) , 2303-11, (2012)] |
High performance liquid chromatography-electrospray ionizati...
2007-05-01 [J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 850(1-2) , 68-73, (2007)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved